A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

reference [dextromethorphan]

single 30 mg oral dose

DRUG

test [PF-00299804 + dextromethorphan]

single 45 mg oral dose of PF-00299804 and a single 30 mg oral dose of dextromethorphan

Trial Locations (1)

Pfizer Investigational Site, Brussels